Study results for enzalutamide vs. bicalutamide in prostate cancer published

Study results for enzalutamide vs. bicalutamide in prostate cancer published

The Phase 2 TERRAIN trial enrolled 375 patients in North America and Europe. The trial enrolled patients with metastatic prostate cancer whose disease progressed despite treatment with a luteinizing hormone-releasing hormone (LHRH) analogue therapy …

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.